Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

NCT ID: NCT04736641

Last Updated: 2021-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are a number of medical assessment tools for various diseases, but in most cases such tools are designed to reflect the perspective of healthcare providers, not perspective of patients. In addition to clinical results, it is necessary to evaluate the quality of life of patients when measuring the effect of medical treatments. Thus, evaluation criteria which can be useful as patient-reported outcome indices, have received increasing attention in recent years. Health-related quality of life provides a patient-reported assessment. Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) evaluates quality of life related to hip disorders. It is also a guide in determining the expectations of individuals in the treatment process. It consists of 3 subscales (pain, movement and mental) and 20 items. Hip condition and pain are evaluated with a 100 mm scale. 20 items are scaled likert with values between 0 and 4. "0" means "strongly agree", "1" means "agree", "2" means "uncertain", "3" means "disagree" and "4" means "strongly disagree". The study is planned with 105 individuals with hip disease. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in JOAHDEQ, Oxford Hip Score, International Hip Outcome Tool-12, Short Form-36, and Visual Analog Scale Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Disease Hip Pain Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients group

Individuals with hip disease and chronic pain on hip

Survey study

Intervention Type OTHER

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey study

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any diagnosed hip disease,
* Chronic hip pain,
* History of pain when lying or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion Criteria

* Lumbar spine nerve root findings,
* History of lumbar spine or hip surgery,
* Corticosteroid injection to hip in the past 3 months.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gazi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Halime ARIKAN

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Halime ARIKAN

Ankara, None Selected, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Halime ARIKAN, MSc.

Role: CONTACT

05465765132

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Halime ARIKAN

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

26.01.2021-E.13996

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.